National Cancer Institute National Cancer Institute
U.S. National Institutes of Health National Cancer Institute
NCI Home Cancer Topics Clinical Trials Cancer Statistics Research & Funding News About NCI
Dictionary of Cancer Terms

Page Options
Print This Page  Print This Page
More NCI Dictionaries
NCI Drug Dictionary

Glossary of Statistical Terms

NCI Dictionary of Genetics Terms

Terminology Resources
Quit Smoking Today
Search for
# A B C D E F G H I J K L M N O P Q R S T U V W X Y Z


18F-fluoromisonidazole (…-FLOOR-oh-MY-soh-NID-uh-sole)

  A radioactive substance being studied as an imaging agent in head and neck cancers and other types of cancer. It binds to large molecules in tumor cells that have a low level of oxygen. Radiation given off by 18F-fluoromisonidazole is detected by a PET scan. The amount of 18F-fluoromisonidazole in the tumor may help decide the best treatment and help predict whether the cancer will come back after treatment. 18F-fluoromisonidazole is a type of radioimaging agent. Also called 18F-MISO and FMISO.

A Service of the National Cancer Institute
Department of Health and Human Services National Institutes of Health USA.gov